Family Office Real Estate Daily · Family Office Real Estate Research Desk · Preview
Research Desk
A curated index of 20,204 CRE market research reports from the major institutional publishers — filterable by asset class, market and publisher. Editorial Family-Office interpretation layer is rolling out report-by-report.
Showing Family Office Briefings with a LP angle — each card surfaces how a family office could deploy capital in that market.
31 reports
Page 1 / 2- NewmarkApr 24, 2026
San Diego Life Science Market Report 1Q26
LP:As a passive LP, a family office could commit to a fund focused on life science properties, although this approach may offer less control over asset management.
- NewmarkApr 24, 2026
Bay Area Life Science Market Report 1Q26
Life ScienceFamily Office Briefing →LP:As a passive LP, a family office could commit to funds focused on life science investments, although this is the least emphasized strategy given current market dynamics.
- NewmarkApr 24, 2026
Boston Life Sciences Market Report 1Q26
LP:As a passive LP, a family office could commit to funds focused on life sciences, although this approach offers less control and customization compared to direct or co-GP investments.
- NewmarkJan 30, 2026
Bay Area Life Science Market Report 4Q25
Life ScienceFamily Office Briefing →LP:As a passive LP, a family office could commit to a life science fund focused on the Bay Area, gaining exposure to the sector without direct management responsibilities.
- NewmarkJan 26, 2026
Boston Life Sciences Market Report 4Q25
LP:As a passive LP, a family office could commit to funds targeting life sciences, although this approach offers less control and customization.
- NewmarkJan 19, 2026
San Diego Life Science Market Report 4Q25
LP:As a passive LP, a family office could commit to funds targeting life science assets, although this approach may limit control over specific investment decisions.
- NewmarkOct 24, 2025
Boston Life Sciences Market Report 3Q25
LP:As a passive LP, a family office could consider commitments to funds focused on life sciences, although this approach may offer less control in a volatile market.
- NewmarkOct 22, 2025
San Diego Life Science Market Report 3Q25
LP:As a passive LP, a family office could commit to a fund focused on life science investments, although this is the least emphasized strategy.
- NewmarkOct 20, 2025
Bay Area Life Science Market Report 3Q25
Life ScienceFamily Office Briefing →LP:As a passive LP, a family office could commit to a fund focused on life science investments, although this is the least emphasized strategy.
- NewmarkAug 6, 2025
San Diego Life Science Market Report 2Q25
LP:Family offices may also consider passive LP commitments in funds targeting distressed life science assets.
- NewmarkJul 28, 2025
Boston Life Sciences Market Report 2Q25
LP:The passive LP angle for a family office could involve committing to funds focused on life sciences, although this is less emphasized given the current market dynamics.
- NewmarkJul 25, 2025
Bay Area Life Science Market Report 2Q25
Life ScienceFamily Office Briefing →LP:As a passive LP, a family office could commit to funds focused on life science, although this approach offers less control compared to direct or co-GP investments.
- NewmarkMay 7, 2025
San Diego Life Science Market Report 1Q25
LP:As a passive LP, a family office may find limited opportunities given the current downturn in venture capital and M&A activity.
- NewmarkMay 7, 2025
Boston Life Sciences Market Report 1Q25
LP:As a passive LP, a family office might consider committing to funds focused on life sciences, although this is the least emphasized strategy given current market conditions.
- NewmarkApr 21, 2025
Bay Area Life Science Market Report 1Q25
Life ScienceFamily Office Briefing →LP:As a passive LP, a family office could commit to a fund focused on life science investments, although this is the least emphasized strategy.
- NewmarkFeb 7, 2025
San Diego Life Science Market Report 4Q24
LP:Family offices can also consider passive LP commitments in life science funds to gain exposure without direct management responsibilities.
- NewmarkJan 22, 2025
Boston Life Sciences Market Report 4Q24
LP:As a passive LP, a family office could commit to funds focused on life sciences, although this approach offers less control over asset management.
- NewmarkJan 20, 2025
Bay Area Life Science Market Report 4Q24
Life ScienceFamily Office Briefing →LP:As a passive LP, a family office could commit to funds focused on the Bay Area life science market, although this is the least emphasized strategy.
- NewmarkJan 17, 2025
Boston Life Sciences Market Report 3Q24
LP:As a passive LP, a family office could commit to funds targeting life sciences, although this approach offers less control compared to direct or co-GP investments.
- NewmarkDec 2, 2024
Bay Area Life Science Market Report 3Q24
Life ScienceFamily Office Briefing →LP:As a passive LP, a family office could commit to a life science fund, although this approach offers less control and customization.
- NewmarkJul 22, 2024
Bay Area Life Science Market Report 2Q24
Life ScienceFamily Office Briefing →LP:The passive LP angle for a family office involves committing capital to a life science fund managed by a seasoned sponsor.
- NewmarkJul 12, 2024
Boston Life Sciences Market Report 2Q24
LP:The passive LP angle for a family office involves committing capital to a life sciences fund managed by a reputable sponsor.
- NewmarkApr 12, 2024
Boston Life Sciences Market Report 1Q24
LP:The passive LP angle for a family office would involve committing capital to a life sciences fund managed by an established sponsor.
- NewmarkJan 22, 2024
Bay Area Life Science Market Report 4Q23
Life ScienceFamily Office Briefing →LP:The passive LP angle for a family office would involve committing capital to a life science fund managed by a reputable sponsor.
Research Hubs
Dedicated pages for every major publisher and market — each with aggregated KPI medians, asset-class breakdowns and the latest reports, read through a family-office lens.